Overwatch Report

Amgen

January–April

[Trade] Conversation on trade policy and the impact on the pharmaceuticals sector

Public Officials Lobbied

{'name': 'Micheál Martin', 'role': 'Taoiseach (Dáil Éireann, the Oireachtas)'}

Amgen

January–April

[Health] Meeting with MEP Cynthia NÍ MHURCHÚ on EU legislation such as the Critical Medicines Act and upcoming Biotech Act

Public Officials Lobbied

{'name': 'Cynthia Ní Mhurchú', 'role': 'MEP (European Parliament)'}

Amgen

January–April

[Health] Email requesting a meeting with MEP Billy Kelleher to discuss EU legislation such as the Critical Medicines Act and upcoming Biotech Act

Public Officials Lobbied

{'name': 'Billy Kelleher', 'role': 'MEP (European Parliament)'}

Amgen

May–August

[Health] Discussion of Critical Medicines Act and other biopharma industry topics

Public Officials Lobbied

{'name': 'Laura Mannion', 'role': 'Special Advisor (Department of Enterprise, Trade and Employment)'} {'name': 'Peter Burke', 'role': 'Minister (Department of Enterprise, Trade and Employment)'}

Amgen

May–August

[Health] Requested a meeting with MEP Kelleher to introduce Amgen and discuss EU General Pharma Legislation, Critical Medicines Act, and the upcoming Biotech Act

Public Officials Lobbied

{'name': 'Billy Kelleher', 'role': 'MEP (European Parliament)'}

RPP SRL

on behalf of Yes (client not named)

May–August

[Health] Let’s Talk Prostate Cancer is supported by a consortium of industry members (including Pfizer, Astellas and Amgen) and expert groups composed of different NGOs focused on cancer policies.

Public Officials Lobbied

{'name': 'Regina Doherty', 'role': 'MEP (European Parliament)'}

Hanover Media Strategy Limited

on behalf of Yes (client not named)

May–August

[Health] Invitation for Taoiseach to attend Amgen Biotech Experience (ABE) event and meeting

Public Officials Lobbied

{'name': 'Joanne Lonergan', 'role': 'Chief of Staff (Department of the Taoiseach)'}

Amgen

May–August

[Health] Request for meeting with Minister Burke regarding life sciences policy

Public Officials Lobbied

{'name': 'Peter Burke', 'role': 'Minister (Department of Enterprise, Trade and Employment)'} {'name': 'Laura Mannion', 'role': 'Special Advisor (Department of Enterprise, Trade and Employment)'}

Amgen

May–August

[Health] Invitation for Taoiseach to attend Amgen Biotech Experience (ABE) event and meeting

Public Officials Lobbied

{'name': 'Simon Harris', 'role': 'An Taoiseach (Department of the Taoiseach)'} {'name': 'Joanne Lonergan', 'role': 'Chief of Staff (Department of the Taoiseach)'}

Amgen

September–December

[Health] Discussed EU pharmaceutical legislation, market access to innovative medicines, and Amgen's manufacturing footprint in Ireland

Public Officials Lobbied

{'name': 'Peter Burke', 'role': 'Minister (Department of Enterprise, Trade and Employment)'}

Amgen

September–December

[Health] Discussed EU pharmaceutical legislation, IP, market access to innovative medicines, and Amgen's manufacturing footprint in Ireland

Public Officials Lobbied

{'name': 'Simon Harris', 'role': 'An Taoiseach (Department of the Taoiseach)'} {'name': 'Max Murphy', 'role': 'Special Adviser (Department of the Taoiseach)'}

Amgen

September–December

[Health] Discussed Amgen's current and future investments in Ireland; discussed EU Pharma Legislation.

Public Officials Lobbied

{'name': 'Peter Burke', 'role': 'Minister (Department of Enterprise, Trade and Employment)'} {'name': 'Pauline Mulligan', 'role': 'Assistant Secretary (Department of Enterprise, Trade and Employment)'}

Amgen

September–December

[Health] Highlight importance of EU Biotech Act and finalization/implementation of EU Pharma Legislation, European Health Data Space, In Vitro Diagnostic Regulation and Clinical Trials Act as part of EU competitiveness.

Public Officials Lobbied

{'name': 'Billy Kelleher', 'role': 'MEP (European Parliament)'} {'name': 'Sean Kelly', 'role': 'MEP (European Parliament)'} {'name': 'Aodhán Ó Ríordáin', 'role': 'MEP (European Parliament)'}

Amgen

September–December

[Health] Discussed EU competitiveness for biopharmaceutical industry investments at ALDE 2024 party conference roundtable; discussed Biotech Act, EU Pharma Legislation, and Draghi Report.

Public Officials Lobbied

{'name': 'Billy Kelleher', 'role': 'MEP (European Parliament)'}

Amgen

September–December

[Health] Requested meetings to discuss need to prioritize EU health policy and enhance EU competitiveness in biotech and life sciences in Ireland

Public Officials Lobbied

{'name': 'Nina Carberry', 'role': 'MEP (European Parliament)'} {'name': 'Barry Andrews', 'role': 'MEP (European Parliament)'} {'name': 'Regina Doherty', 'role': 'MEP (European Parliament)'} {'name': 'Billy Kelleher', 'role': 'MEP (European Parliament)'} {'name': 'Sean Kelly', 'role': 'MEP (European Parliament)'}

Amgen

September–December

[Health] Discussed regulation, need to keep EU competitive and support more clinical trials in Europe as part of AmCham EU delgation

Public Officials Lobbied

{'name': 'Sean Kelly', 'role': 'MEP (European Parliament)'}

Lobbying Tracker

Most Lobbied TDs